0001127602-11-011160.txt : 20110324 0001127602-11-011160.hdr.sgml : 20110324 20110324173839 ACCESSION NUMBER: 0001127602-11-011160 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110322 FILED AS OF DATE: 20110324 DATE AS OF CHANGE: 20110324 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Haluska Frank CENTRAL INDEX KEY: 0001494892 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21696 FILM NUMBER: 11710341 MAIL ADDRESS: STREET 1: C/O ARIAD PHARMACEUTICALS, INC. STREET 2: 26 LANDSDOWNE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARIAD PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000884731 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 223106987 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 26 LANDSDOWNE ST CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6174940400 MAIL ADDRESS: STREET 1: 26 LANDSDOWNE CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 form4.xml PRIMARY DOCUMENT X0303 4 2011-03-22 0000884731 ARIAD PHARMACEUTICALS INC ARIA 0001494892 Haluska Frank C/O ARIAD PHARMACEUTICALS, INC. 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 1 VP, Clinical R&D, CMO Common Stock 2011-03-22 4 M 0 13334 0 A 28265 D Common Stock 2011-03-22 4 F 0 4400 6.39 D 23865 D Restricted Stock Units 0 2011-03-22 4 M 0 13334 0 D 2020-03-22 Common Stock 13334 26666 D The restricted stock units will vest 33.33% on March 22, 2011, 2012, and 2013. 13,334 shares will be delivered to the reporting person on or about March 22, 2011 and 13,333 shares will be delivered to the reporting person on or about each of March 22, 2012 and 2013. Represents shares withheld to satisfy withholding tax requirements. Shares were acquired upon vesting of restricted stock units awarded on 03/22/2010. /s/Edward M. Fitzgerald, Attorney-in-Fact 2011-03-24